Department of Obstetrics and Gynaecology

Evaluating the potential of ChatGPT for patient identification in clinical breast cancer trials (2025) Krückel A, Fasching P, Schleicher O, Gocke J, Brückner L, Seitz K, Häberle L, et al. Journal article Investigating Real-World Evidence and Reported Survival Outcomes of CDK4/6 Inhibitors in HR+/HER2− Advanced Breast Cancer (2025) Sammons S, Yardley DA, Sharma P, Gadi VK, Pegram M, Pathak P, Hu H, et al. Journal article Sonographischer Zufallsbefund mit 35 Schwangerschaftswochen und unmittelbarer therapeutischer Konsequenz: Die Rolle sorgfältiger pränataler Diagnostik in der Prävention schwerwiegender geburtshilflicher Komplikationen (2025) Weidenthaler F, Mocker A, Anetsberger D, Titzmann A, Schneider M Journal article Die zertifizierte Versorgungskette in der gynäkologischen Onkologie mit Integration personalisierter Medizin (2025) Stübs F, Pöschke P, Beckmann M, Dannecker C, Ortmann O, Emons J Journal article Compatibility of family and clinical–scientific career for German gynecologists in different workplaces: a sub-analysis of the systematic trinational FARBEN survey (2025) Amann N, Banys-Paluchowski M, Becker C, Foessleitner P, Göpfert M, Kiblawi R, Kiessling N, et al. Journal article Onkopedia: What’s New? Systemic Tumor Treatment in Pregnancy (2025) Maschmeyer G, Fehm T, Loibl S, Dittrich R, Hilgendorf I Journal article A comparative evaluation of publicly available large language models in the assessment of CTG traces according to the FIGO criteria (2025) Psilopatis I, Monod C, Filippi V, Tschudin R, Lapaire O, Emons J, Mosimann B, Zwimpfer TA Journal article Leveraging artificial intelligence for evidence-based recommendations in uterine fibroid therapy: Addressing the unmet need in German healthcare—A clinical trial (2025) Psilopatis I, Lotz L, Sipulina N, Heindl F, Levidou G, Emons J Journal article Verhütungsberatung - zwischen Wunsch und Wirklichkeit die richtige Wahl treffen (2025) Bozzetti T, Hofbeck L, Au K Journal article Invasive disease-free and overall survival after (neo)adjuvant chemotherapy in postmenopausal patients with hormone receptor-positive, HER2-negative early breast cancer treated with upfront letrozole: Experiences from the phase IV PreFace trial (2025) Beierlein M, Häberle L, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, et al. Journal article